Emily A. Abcede is a San Diego, California based nurse practitioner who is specialized as Pediatrics nurse. Her current practice location is 3020 Childrens Way, San Diego. Patients can reach her at 858-966-5855 or can fax her at 858-966-7903. Emily A. Abcede is ARNP, CPNP with specialization in Pediatrics and her NPI number (Unique professional ID assigned by NPPES) is 1548654916. Emily A. Abcede specializes in caring for newborns, infants, toddlers, adolescents and young adults. She perform pediatric health care maintenance, including well child exams, developmental screenings and in-depth physical assessments, such as vision, hearing and dental. Pediatrics Nurse Practitioner (PNP) focus on well-child care and the prevention or management of common pediatric acute illnesses and chronic conditions.
Complete Profile:
Emily A. Abcede speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Emily A. Abcede
Specialization:
Pediatrics Nurse Practitioner (PNP)
Gender:
Female
Credentials:
ARNP, CPNP
Practice Address:
3020 Childrens Way, San Diego, California, 92123-4223
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1548654916
NPI Enumeration Date:
24 Mar, 2015
NPI Last Update On:
10 Mar, 2022
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Emily A. Abcede 3020 Childrens Way # Mc5003, San Diego, California
Zip:
92123-4223
Phone Number:
858-309-6300
Patients can reach Emily A. Abcede at 3020 Childrens Way, San Diego, California or can call to book an appointment on 858-966-5855.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.